Skip to content

NICE Ltd

US · NICE #1814 by market cap Listed 1970
116.42 +1.09 +0.95%
Live - 5344 symbols - heartbeat 337s ago · 2026-10-08 04:00
Pre-market 116.42 0.00%
After-hours 116.42 0.00%
Market cap
6.92B
P/B
1.83
EPS
9.67
Reader sentiment Are you bullish or bearish on NICE?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 4 in the most recent period (2026/Q3).
  • Total institutional ownership fell 1.6 percentage points.

Institutional ownership

Held by institutions
78.37% -1.59pp
Institutions
473 -4
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund69.38%
Public Company3.13%
Hedge Fund3.08%
Government Pension Fund1.00%
Private Company0.95%
Sovereign Wealth Fund0.45%
Individual/Insider0.41%
Family Office/Trust0.21%
Corporate Pension Plan0.11%
Other21.27%

Top holders as of 2026-06-30

Principal Global Investors, LLC 7.77% · 4.55M sh
Brandes Investment Partners, LP 4.88% · 2.86M sh
Fidelity International Ltd 4.58% · 2.69M sh
Harding Loevner LP 4.31% · 2.52M sh
BlackRock 4.25% · 2.49M sh
Vanguard Capital Management, LLC 3.70% · 2.17M sh
Clal Financial Management Ltd 2.72% · 1.59M sh
Menora Mivtachim Provident Funds 2.46% · 1.44M sh
UBS Asset Management 2.00% · 1.17M sh
Neuberger Berman Investment Advisers LLC 1.96% · 1.15M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 10 buys · 19 sells

NameRoleStake
Scott Russell Chief Executive Officer 0.23%
Beth Gaspich Chief Financial Officer 0.11%
David Kostman Independent Chairperson 0.03%
Joseph Cowan Independent Director 0.03%
Zehava Simon Independent Outside Director 0.01%
Rimon Ben-Shaoul Independent Director 0.01%
Yocheved Dvir Independent Outside Director 0.01%
Caroline Tsay Director 0.00%
Dan Falk Independent Outside Director 0.00%
Leo Apotheker Independent Director --

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-30 Scott Russell Chief Executive Officer Sale to Issuer -2,051 $111.27
2026-09-29 David Kostman Independent Chairperson Sale to Issuer -5 $106.81
2026-09-29 Joseph Cowan Independent Director Sale to Issuer -3 $106.81
2026-09-29 Caroline Tsay Director Sale to Issuer -3 $106.81
2026-09-07 Shiri Neder Officer Other Derivative Acquisition +7,500 $0.33
2026-08-12 Zehava Simon Independent Outside Director Derivative Exercise and Retained +554 $0.31
2026-08-06 Udi Dayan -- Derivative Exercise and Sale -500 $0.31–100.00
2026-06-30 Scott Russell Chief Executive Officer Sale to Issuer -2,051 $90.85
2026-06-14 Yocheved Dvir Independent Outside Director Derivative Exercise and Retained +3,036 $0.27–0.31
2026-06-08 Scott Russell Chief Executive Officer Other Acquisition +70,000 --
2026-06-08 Scott Russell Chief Executive Officer Other Derivative Acquisition +28,000 --
2026-06-02 Dan Falk Independent Outside Director Derivative Exercise and Retained +696 $0.29
2026-06-02 Rimon Ben-Shaoul Independent Director Derivative Exercise and Retained +3,036 $0.27–0.31
2026-05-12 Zehava Simon Independent Outside Director Derivative Exercise and Retained +696 $0.29
2026-03-31 Alon Levy General Counsel Other Derivative Acquisition +5,000 $0.32
2026-03-31 Scott Russell Chief Executive Officer Sale to Issuer -2,051 $110.26
2026-03-31 Udi Dayan -- Other Derivative Acquisition +5,000 $0.32
2026-03-17 Dan Falk Independent Outside Director Initial Statement of Beneficial 0 --
2026-03-17 Rimon Ben-Shaoul Independent Director Initial Statement of Beneficial 0 --
2026-03-17 David Kostman Independent Chairperson Initial Statement of Beneficial 0 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 04:00:03 · For reference only, not investment advice and not tailored to your situation.